BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14574707)

  • 1. Catalytic features of monoclonal antibody i41SL1-2 subunits.
    Hifumi E; Kondo H; Mitsuda Y; Uda T
    Biotechnol Bioeng; 2003 Nov; 84(4):485-93. PubMed ID: 14574707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic antibody light chain capable of cleaving a chemokine receptor CCR-5 peptide with a high reaction rate constant.
    Mitsuda Y; Hifumi E; Tsuruhata K; Fujinami H; Yamamoto N; Uda T
    Biotechnol Bioeng; 2004 Apr; 86(2):217-25. PubMed ID: 15052642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endopeptidase character of monoclonal antibody i41-7 subunits.
    Hatiuchi K; Hifumi E; Mitsuda Y; Uda T
    Immunol Lett; 2003 May; 86(3):249-57. PubMed ID: 12706527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic digestion of human tumor necrosis factor-α by antibody heavy chain.
    Hifumi E; Higashi K; Uda T
    FEBS J; 2010 Sep; 277(18):3823-32. PubMed ID: 20718866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Super catalytic antibodies (antigenase) capable of destroying H. pylori urease].
    Taizo U; Hifumi E; Okamura Y
    Nihon Rinsho; 2006 Feb; 64(2):286-92. PubMed ID: 16454183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly efficient method of preparing human catalytic antibody light chains and their biological characteristics.
    Hifumi E; Honjo E; Fujimoto N; Arakawa M; Nishizono A; Uda T
    FASEB J; 2012 Apr; 26(4):1607-15. PubMed ID: 22205784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of multicatalytic monoclonal antibodies.
    Zein HS; da Silva JA; Miyatake K
    Mol Immunol; 2010 May; 47(9):1747-56. PubMed ID: 20356628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Super catalytic antibody and antigenase.
    Uda T; Hifumi E
    J Biosci Bioeng; 2004; 97(3):143-52. PubMed ID: 16233607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S; Monson N; Ball WJ
    Proteins; 2005 Aug; 60(3):382-91. PubMed ID: 15971203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How and why 41S-2 antibody subunits acquire the ability to catalyze decomposition of the conserved sequence of gp41 of HIV-1.
    Hifumi E; Okamoto Y; Uda T
    Appl Biochem Biotechnol; 2000; 83(1-3):209-19; discussion 219-20, 297-313. PubMed ID: 10826961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific degradation of H. pylori urease by a catalytic antibody light chain.
    Hifumi E; Hatiuchi K; Okuda T; Nishizono A; Okamura Y; Uda T
    FEBS J; 2005 Sep; 272(17):4497-505. PubMed ID: 16128818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a serine protease-like catalytic triad on an antibody light chain displayed on the yeast cell surface.
    Okochi N; Kato-Murai M; Kadonosono T; Ueda M
    Appl Microbiol Biotechnol; 2007 Dec; 77(3):597-603. PubMed ID: 17899065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic activity of an antibody light chain.
    Sun M; Gao QS; Li L; Paul S
    J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of active form of catalytic antibody light chain 41S-2-L.
    Mitsuda Y; Tsuruhata K; Hifumi E; Takagi M; Uda T
    Immunol Lett; 2005 Jan; 96(1):63-71. PubMed ID: 15585309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for amide hydrolysis catalyzed by the 43C9 antibody.
    Thayer MM; Olender EH; Arvai AS; Koike CK; Canestrelli IL; Stewart JD; Benkovic SJ; Getzoff ED; Roberts VA
    J Mol Biol; 1999 Aug; 291(2):329-45. PubMed ID: 10438624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic and biochemical features of a monoclonal antibody heavy chain, JN1-2, raised against a synthetic peptide with a hemagglutinin molecule of influenza virus.
    Hifumi E; Takao S; Fujimoto N; Uda T
    J Am Chem Soc; 2011 Sep; 133(38):15015-24. PubMed ID: 21861493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characterization of mouse monoclonal antibody 13-1 against a porphyrin derivative: identification of a disulfide bond in CDR-H3 of Mab 13-1.
    Akashi S; Kato K; Torizawa T; Dohmae N; Yamaguchi H; Kamachi M; Harada A; Imanaka T; Shimada I; Takio K
    Biochem Biophys Res Commun; 1997 Nov; 240(3):566-72. PubMed ID: 9398605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate antibody catalysis.
    Gololobov G; Sun M; Paul S
    Mol Immunol; 1999 Dec; 36(18):1215-22. PubMed ID: 10684961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural properties and mutation patterns of anti-nucleosome monoclonal antibodies are similar to those of anti-DNA antibodies.
    Brard F; Jovelin F; Petit S; Tron F; Gilbert D
    Eur J Immunol; 1996 Jul; 26(7):1587-94. PubMed ID: 8766565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.